Ceangail le linn

EU

100 milliún othar ionchasacha 'Ní maith ar an eolas' ar roghanna sláinte trasteorann

ROINN:

foilsithe

on

Úsáidimid do shíniú suas chun ábhar a sholáthar ar bhealaí ar thoiligh tú leo agus chun ár dtuiscint ortsa a fheabhsú. Is féidir leat díliostáil ag am ar bith.

20150422PHT44602_originalBy Chomhghuaillíocht Eorpach do Leigheas phearsantaithe Stiúrthóir Feidhmiúcháin Denis Horgan

A major survey undertaken on behalf of the European Commission has shown that the experience of cross-border health care in the EU has changed little since 2007.

This is despite the implementation of a Directive on patients’ rights in cross-border health care more than a year prior to the poll.

Aiseolas

Back in 2011, a directive proposed by the Commission on the application of patients’ rights in cross-border health-care was adopted by the European Parliament and the European Council. The directive entered into force at the end of 2013 across all member states.  Its objectives were to provide clear rules and reliable information to patients regarding access and reimbursement for healthcare received in another EU country, “to meet patients' expectations of the highest-quality health care when travelling abroad and to ensure EU countries work closer together in the interest of patients”.

For the report, nearly 28,000 people, coming from different social and demographic groups, were interviewed across all 28 member states at the end of October 2014, on behalf of the Commission’s Directorate-General for Health and Consumers (SANCO).  It found that one-in-twenty patients said they had experienced medical treatment in another EU country in the last year, which equates to an increase of just 1% on 2007.

Yet around half would be willing to travel to another EU country for medical treatment with the most common reasons for patients doing so being to receive treatment unavailable in their own member state and/or to receive better quality treatment.  Indeed, in 26 of the 28 member states, the key reason given by people was to receive treatment that is not available in their own country although, in two countries, this came after the desire to receive better quality treatment.

Aiseolas

Countries where people were the most open to cross-border health care tended to be those living in smaller countries, such as Malta, the Netherlands, Cyprus, Denmark and Luxembourg. Patients were least prepared to seek treatment abroad in Germany, Finland, France and Austria, as well as in Belgium and Lithuania.  Around 55% of those asked said that the main reason for not wanting to get treatment in another country was that they were satisfied with the medical treatment they received in their own, while possible language difficulties were an issue for more than one quarter of those asked. And, not surprisingly, just under half of Europeans felt that “it was more convenient to be treated near home”.

In a strange choice of words, the report states that “lack of knowledge and awareness is not listed among the main reasons for not receiving treatment abroad today. Indeed, only 21% of the respondents who did not seek treatment abroad said that they ‘do not have enough information about the availability and quality of medical treatments abroad’.”

Please note and consider that phrase, “only 21%”.

In a 28-member state EU that figure “only” equates to more than 100 million potential patients who did not seek treatment abroad because they have a ‘lack of knowledge or awareness’ of cross-border treatment.

A little further into the report we learn that around the same number "do not have enough information about the availability and quality of medical treatments abroad".  The Brussels-based European Alliance for Personalised Medicine (EAPM) would very much like to highlight here the fact that 100 million is a great many people.

Later, the report concedes that patients only seem to have partial knowledge of their rights to cross-border health care, with less than 30% knowing that they can get a prescription from their doctor to use in another EU country. On top of this, only a ‘small minority’ knew when prior authorization was needed before seeking treatment in another EU country, with the legislation being complicated and differing from member state to member state.

The bottom-line is that most Europeans who were asked did not feel well-informed about the types of health care they have the right to be reimbursed for in another EU country – a massive 78%. Clearly, there are some large gaps in public knowledge and, doubtless, among GPs too.

Crucially, while 50% of those asked said they feel informed about their right to be reimbursed for healthcare in their own country, a staggering 80+% feel less-than-well informed about their rights when being treated in another EU country, with only one-in-ten having heard of the National Contact Point that provides information about EU cross-border health care.

For certain, there is no doubt that the provision of cross-border health services, reimbursement policies and coverage by national health-care systems is a highly complex affair, but nearly four-fifths of people not feeling well-informed is surely excessively high.  Meanwhile, the survey once again uses the word ‘only’ to describe the 15% of respondents who encountered problems getting reimbursed for cross-border treatments with the vast majority – 69% – saying they had had no problems getting reimbursed back home. Presumably, the missing 16% had at least some difficulties.

For example, Maria, a 28-year-old cancer sufferer from Valetta, told EAPM: “Not only did I have to dig out the information on where to go outside my own country, I also had considerable issues being reimbursed. It’s not easy in the first place to leave home for treatment, and this only makes it harder.”

And Finn, a 63-year-old from Copenhagen, revealed that he wasted more than a year hunting down treatment for his rare disease and lost time and quality of life “because I simply was not made aware of my options”.

EAPM strongly believes that the provision of cross-border health care is vital to giving the best treatment possible to all patients in the EU who need and want it, and that for its part the European Union should go much further down the line of encouraging member states to inform patients, and those who treat them, of their rights.

The Alliance believes that support to member states on streamlining their reimbursement procedures and making them more efficient, and with less red tape, is also an urgent requirement.  The facts about what works and what doesn’t in cross-border health care are in the report – it is time to act.

 

 

An Coimisiún Eorpach

NextGenerationEU: Íocann an Coimisiún Eorpach € 231 milliún i réamh-mhaoiniú chun na Slóivéine

foilsithe

on

D'eisigh an Coimisiún Eorpach € 231 milliún leis an tSlóivéin i réamh-mhaoiniú, arb ionann é agus 13% de leithdháileadh deontais na tíre faoin tSaoráid Aisghabhála agus Athléimneachta (RRF). Cuideoidh an íocaíocht réamh-mhaoinithe le cur i bhfeidhm na mbeart ríthábhachtach infheistíochta agus athchóirithe a leagtar amach i bplean téarnaimh agus athléimneachta na Slóivéine a thosú. Údaróidh an Coimisiún eisíocaíochtaí breise bunaithe ar chur i bhfeidhm na n-infheistíochtaí agus na n-athchóirithe a leagtar amach i bplean téarnaimh agus athléimneachta na Slóivéine.

Tá sé beartaithe go bhfaighidh an tír € 2.5 billiún san iomlán, comhdhéanta de € 1.8bn i ndeontais agus € 705m in iasachtaí, thar shaolré a plean. Tagann eisíocaíocht an lae inniu tar éis na chéad oibríochtaí iasachta faoi NextGenerationEU a chur i bhfeidhm go rathúil le déanaí. Faoi dheireadh na bliana, tá sé beartaithe ag an gCoimisiún suas le € 80 billiún a chruinniú i maoiniú fadtéarmach, le comhlánú le Billí gearrthéarmacha AE, chun na chéad eisíocaíochtaí pleanáilte a mhaoiniú do bhallstáit faoi NextGenerationEU.

Tá an RRF i gcroílár NextGenerationEU a sholáthróidh € 800bn (i bpraghsanna reatha) chun tacú le hinfheistíochtaí agus athchóirithe ar fud na mballstát. Tá plean na Slóivéine mar chuid d’fhreagairt gan fasach an AE teacht chun cinn níos láidre ó ghéarchéim COVID-19, ag cothú na n-aistrithe glasa agus digiteacha agus ag athléimneacht agus comhtháthú inár sochaithe a neartú. A. brúigh scaoileadh ar fáil ar líne.

Aiseolas

Leanúint ar aghaidh Léitheoireachta

An Chipir

NextGenerationEU: Íocann an Coimisiún Eorpach € 157 milliún i réamh-mhaoiniú chun na Cipire

foilsithe

on

D'eisigh an Coimisiún Eorpach € 157 milliún don Chipir i réamh-mhaoiniú, arb ionann é agus 13% de leithdháileadh airgeadais na tíre faoin tSaoráid Aisghabhála agus Athléimneachta (RRF). Cuideoidh an íocaíocht réamh-mhaoinithe le cur i bhfeidhm na mbeart ríthábhachtach infheistíochta agus athchóirithe a leagtar amach i bplean téarnaimh agus athléimneachta na Cipire a thosú. Údaróidh an Coimisiún eisíocaíochtaí breise bunaithe ar chur i bhfeidhm na n-infheistíochtaí agus na n-athchóirithe a leagtar amach i bplean téarnaimh agus athléimneachta na Cipire.

Tá sé beartaithe go bhfaighidh an tír € 1.2 billiún san iomlán thar shaolré a plean, agus soláthrófar € 1 billiún i ndeontais agus € 200m in iasachtaí. Tagann eisíocaíocht an lae inniu tar éis na chéad oibríochtaí iasachta faoi NextGenerationEU a chur i bhfeidhm go rathúil le déanaí. Faoi dheireadh na bliana, tá sé beartaithe ag an gCoimisiún suas le € 80bn san iomlán a chruinniú i maoiniú fadtéarmach, le comhlánú ag Billí gearrthéarmacha AE, chun na chéad eisíocaíochtaí pleanáilte a mhaoiniú do bhallstáit faoi NextGenerationEU. Mar chuid de NextGenerationEU, soláthróidh an RRF € 723.8bn (i bpraghsanna reatha) chun tacú le hinfheistíochtaí agus athchóirithe ar fud na mballstát.

Tá plean na Cipire mar chuid d’fhreagairt gan fasach an AE teacht chun cinn níos láidre ó ghéarchéim COVID-19, ag cothú na n-aistrithe glasa agus digiteacha agus ag neartú athléimneacht agus comhtháthaithe inár sochaithe. A. brúigh scaoileadh ar fáil ar líne.

Aiseolas

Leanúint ar aghaidh Léitheoireachta

Belgium

Beartas Comhtháthaithe an AE: Faigheann an Bheilg, an Ghearmáin, an Spáinn agus an Iodáil € 373 milliún chun tacú le seirbhísí sláinte agus sóisialta, FBManna agus cuimsiú sóisialta

foilsithe

on

Dheonaigh an Coimisiún € 373 milliún do chúig Ciste Sóisialta na hEorpa (CSE) agus Ciste Forbraíochta Réigiúnaí na hEorpa Cláir oibríochta (ERDF) sa Bheilg, sa Ghearmáin, sa Spáinn agus san Iodáil chun cabhrú leis na tíortha a bhfuil freagairt agus deisiú éigeandála coronavirus acu faoi chuimsiú na REACT-AE. Sa Bheilg, cuirfidh modhnú an Wallonia OP € 64.8m breise ar fáil chun trealamh míochaine a fháil le haghaidh seirbhísí sláinte agus nuálaíochta.

Tacóidh na cistí le gnóthais bheaga agus mheánmhéide (FBManna) chun ríomhthráchtáil, cibearshlándáil, láithreáin ghréasáin agus siopaí ar líne a fhorbairt, chomh maith leis an ngeilleagar glas réigiúnach trí éifeachtúlacht fuinnimh, cosaint an chomhshaoil, forbairt cathracha cliste agus ísealcharbóin bonneagair phoiblí. Sa Ghearmáin, i Stát Cónaidhme Hessen, tacóidh € 55.4m le bonneagar taighde a bhaineann le sláinte, cumas diagnóiseach agus nuálaíocht in ollscoileanna agus in institiúidí taighde eile chomh maith le hinfheistíochtaí taighde, forbartha agus nuálaíochta i réimsí na haeráide agus na forbartha inbhuanaithe. Cuirfidh an leasú seo tacaíocht ar fáil do FBManna agus do chistí do ghnólachtaí nuathionscanta trí chiste infheistíochta.

I Sachsen-Anhalt, éascóidh € 75.7m comhoibriú FBManna agus institiúidí i dtaighde, forbairt agus nuálaíocht, agus infheistíochtaí agus caipiteal oibre a sholáthar do mhicrifhiontair a dtéann an ghéarchéim coronavirus i bhfeidhm orthu. Thairis sin, ligfidh na cistí d’infheistíochtaí in éifeachtúlacht fuinnimh fiontar, tacóidh siad le nuálaíocht dhigiteach i FBManna agus trealamh digiteach a fháil do scoileanna agus d’institiúidí cultúrtha. San Iodáil, gheobhaidh an OP náisiúnta ‘Cuimsiú Sóisialta’ € 90m chun comhtháthú sóisialta daoine a bhfuil díothacht mór ábhair, easpa dídine nó imeallú mór orthu a chur chun cinn, trí sheirbhísí ‘Housing First’ a chomhcheanglaíonn soláthar tithíochta láithreach le seirbhísí sóisialta agus fostaíochta a chumasú. .

Aiseolas

Sa Spáinn, cuirfear € 87m leis an ESF OP do Castilla y León chun tacú le daoine féinfhostaithe agus oibrithe a raibh a gconarthaí curtha ar fionraí nó laghdaithe mar gheall ar an ngéarchéim. Cuideoidh an t-airgead le cuideachtaí crua freisin layoffs a sheachaint, go háirithe in earnáil na turasóireachta. Faoi dheireadh, teastaíonn na cistí chun ligean do sheirbhísí sóisialta riachtanacha leanúint ar aghaidh ar bhealach sábháilte agus leanúnachas oideachais a chinntiú ar fud na paindéime trí bhaill foirne breise a fhostú.

Tá REACT-EU mar chuid de NextGenerationEU agus soláthraíonn sé maoiniú breise € 50.6bn (i bpraghsanna reatha) do chláir bheartais Chomhtháthaithe le linn 2021 agus 2022. Díríonn bearta ar thacú le hathléimneacht mhargadh an tsaothair, poist, FBManna agus teaghlaigh ar ioncam íseal, chomh maith le bunsraitheanna a bheidh oiriúnach don todhchaí a leagan síos do na haistrithe glasa agus digiteacha agus téarnamh socheacnamaíoch inbhuanaithe.

Aiseolas

Leanúint ar aghaidh Léitheoireachta
Aiseolas
Aiseolas
Aiseolas

trending